SHANGHAI, Jan. 10, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, today announced that it will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 3:30 p.m. Pacific Standard Time and updated its 2010 financial guidance. Based on preliminary, unaudited results, WuXi expects to slightly exceed the top end of its previous guidance for 2010 total net revenues of $330-333 million and to exceed year-over-year growth in 2010 non-GAAP operating income of 28-32%. The company also expects to achieve the remainder of the 2010 financial guidance found in its third-quarter 2010 earnings release.
The company plans to report its audited fourth-quarter and full-year 2010 financial results and to provide 2011 financial guidance in March 2011.
WuXiPharmaTech(Cayman)Inc. Ronald Aldridge (for investors) Director of Investor Relations Tel: +1-201-585-2048 Email: [email protected]
StephanieLiu(forthemedia) WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-4362 Email: [email protected]